Thurau S - Search Results

1

Posterior subcapsular cataracts are a late effect after acute exposure to 0.5 Gy ionizing radiation in mice.

Kunze S, Cecil A, Prehn C, Möller G, Ohlmann A, Wildner G, Thurau S, Unger K, Rößler U, Hölter SM, Tapio S, Wagner F, Beyerlein A, Theis F, Zitzelsberger H, Kulka U, Adamski J, Graw J, Dalke C. Kunze S, et al. Among authors: thurau s. Int J Radiat Biol. 2021;97(4):529-540. doi: 10.1080/09553002.2021.1876951. Epub 2021 Mar 1. Int J Radiat Biol. 2021. PMID: 33464160

2

Lymphocytes, macrophages and HLA-DR expression in vitreal and epiretinal membranes of proliferative vitreoretinopathy. An immunohistochemical study.

Tang S, Scheiffarth OF, Wildner G, Thurau SR, Lund OE. Tang S, et al. Among authors: thurau sr. Ger J Ophthalmol. 1992;1(3-4):176-9. Ger J Ophthalmol. 1992. PMID: 1483132

3

Expression and immunogenicity of HLA-B27 in high-transfection recipient P815: a new method to induce monoclonal antibodies directed against HLA-B27.

Thurau SR, Wildner G, Kuon W, Weiss EH, Riethmüller G. Thurau SR, et al. Tissue Antigens. 1989 May;33(5):511-9. doi: 10.1111/j.1399-0039.1989.tb01702.x. Tissue Antigens. 1989. PMID: 2508265

4

Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.

Wildner G, Thurau SR. Wildner G, et al. Among authors: thurau sr. Eur J Immunol. 1995 May;25(5):1292-7. doi: 10.1002/eji.1830250524. Eur J Immunol. 1995. PMID: 7774632

5

Cross-reactivity between an HLA-B27-derived peptide and a retinal autoantigen peptide: a clue to major histocompatibility complex association with autoimmune disease.

Wildner G, Thurau SR. Wildner G, et al. Among authors: thurau sr. Eur J Immunol. 1994 Nov;24(11):2579-85. doi: 10.1002/eji.1830241103. Eur J Immunol. 1994. PMID: 7957552

6

Orally induced, peptide-specific gamma/delta TCR+ cells suppress experimental autoimmune uveitis.

Wildner G, Hünig T, Thurau SR. Wildner G, et al. Among authors: thurau sr. Eur J Immunol. 1996 Sep;26(9):2140-8. doi: 10.1002/eji.1830260927. Eur J Immunol. 1996. PMID: 8814259

7

Database screening for molecular mimicry.

Wildner G, Thurau SR. Wildner G, et al. Among authors: thurau sr. Immunol Today. 1997 May;18(5):252. doi: 10.1016/s0167-5699(97)90086-4. Immunol Today. 1997. PMID: 9153958 No abstract available.

8

Molecular mimicry as a therapeutic approach for an autoimmune disease: oral treatment of uveitis-patients with an MHC-peptide crossreactive with autoantigen--first results.

Thurau SR, Diedrichs-Möhring M, Fricke H, Arbogast S, Wildner G. Thurau SR, et al. Immunol Lett. 1997 Jun 1;57(1-3):193-201. doi: 10.1016/s0165-2478(97)00058-8. Immunol Lett. 1997. PMID: 9232451 Clinical Trial.

9

Oral tolerance in autoimmune uveitis.

Wildner G, Thurau SR. Wildner G, et al. Among authors: thurau sr. Dev Ophthalmol. 1999;31:67-76. doi: 10.1159/000060757. Dev Ophthalmol. 1999. PMID: 10641200 Review. No abstract available.

10

Induction of arthritis and uveitis in Lewis rats by antigenic mimicry of peptides from HLA-B27 and cytokeratin.

Wildner G, Diedrichs-Möhring M, Thurau SR. Wildner G, et al. Eur J Immunol. 2002 Jan;32(1):299-306. doi: 10.1002/1521-4141(200201)32:1<299::AID-IMMU299>3.0.CO;2-Q. Eur J Immunol. 2002. PMID: 11782021 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

101 results

Search Page